An activist shareholder demanding changes, soaring medical costs, and a $68 billion deal for Aetna. Read More
We współpracy z: https://fortune.com/2024/10/21/what-went-wrong-at-cvs/
Brad Garlinghouse Takes Aim At Strategy’s Debt-Fueled Bitcoin Play
[[{„value”:” TL;DR Ripple CEO Brad Garlinghouse argued that Strategy’s model of leveraging preferred stock and debt to buy…
